Moderna expects to produce by the end of 2020. 20 million doses of mRNA-1273 coronavirus vaccine, and in 2021 from 500 million to 1 billion doses. Earlier, the US administration allocated $486 million to the company for vaccine development.
Moderna expects to produce by the end of 2020. 20 million doses of mRNA-1273 coronavirus vaccine, and in 2021 from 500 million to 1 billion doses. Earlier, the US administration allocated $486 million to the company for vaccine development. 
tass.ru
English (US) 